Live
- Sudanese army recaptures capital of Sinnar State in central Sudan
- Kishkindha Kaandam Review: Some movies prove not to compromise in having a good cinematic experience and this is one of them
- Son-rise: Hemant Soren grows taller as tribal leader, makes father proud
- ISL 2024-25: 10-man NorthEast United FC hold on to take three points vs Punjab FC
- BGT 2024-25: Jaiswal’s application, commitment to form a partnership was so impressive, says Gilchrist
- BGT 2024-25: Personally, I am very happy with my performance, says Harshit Rana
- Pakistan's Lahore remains world's most polluted city despite light drizzle
- Asha Nautiyal retains Kedarnath for BJP, to be back as MLA after 12 years
- India leads world in science, innovation research: Minister
- Flash flood in Indonesia's South Tapanuli claims two lives
KTR extends wishes to Hyderabad biotech firm to develop vaccine for coronavirus
Telangana minister KT Rama Rao extended best wishes to Hyderabad biotech company Bharat Biotech which is striving to develop the 'CoroFlu' vaccine for the prevention of coronavirus.
Telangana minister KT Rama Rao extended best wishes to Hyderabad biotech company Bharat Biotech which is striving to develop the 'CoroFlu' vaccine for the prevention of coronavirus. The minister greeted the company managing director Dr. Krishna Ella and the team in the development of the vaccine.
My best wishes to our own Hyderabad Biotech company @BharatBiotech as they strive to develop a vaccine #CoroFlu for #CoronaVirus prevention
— KTR (@KTRTRS) April 4, 2020
Good luck in your endeavour CMD Dr. Krishna Ella and team. Wish you all success 👍 pic.twitter.com/Ivd1t3KePf
Bharat Biotech Ltd, a Hyderabad-based firm has joined hands with the University of Wisconsin-Madison and US-based company FluGen to develop 'CoroFlu'. The company said that the vaccine will be based on FluGen's flu vaccine candidate M2SR. "The gene sequences from coronavirus SARS-CoV2 will be placed into the vaccine candidate for additional immunity to fight against coronavirus," Bharat Biotech said.
Raches Ella, managing director of Bharat Biotech in a statement said that the company would produce 300 million doses of vaccine for global distribution.
